What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Antibody
His main research concerns Immunology, Antibody, Genotype, Allele and Odds ratio.
His Immunology research is multidisciplinary, incorporating perspectives in Disease and Locus.
The study incorporates disciplines such as Meningitis and Virology in addition to Antibody.
In his research, Distribution is intimately related to Cytokine, which falls under the overarching field of Genotype.
His research integrates issues of Juvenile dermatomyositis, Dermatomyositis, Etiology and Immunopathology in his study of Odds ratio.
His work carried out in the field of Allotype brings together such families of science as Immunoglobulin G and Haemophilus influenzae.
His most cited work include:
- Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection (277 citations)
- HLA-DRB1*1101: A Significant Risk Factor for Sarcoidosis in Blacks and Whites (252 citations)
- Interleukin-1beta+3953 allele 2: association with disease status in adult periodontitis. (213 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Immunology, Antibody, Genotype, Allele and Immunoglobulin Allotypes.
His study brings together the fields of Virology and Immunology.
His Antibody research entails a greater understanding of Genetics.
Janardan P. Pandey has included themes like Odds ratio and Pathogenesis in his Genotype study.
His research in Allele intersects with topics in Genotyping, Locus and Population study.
In his work, Microbiology is strongly intertwined with Haemophilus influenzae, which is a subfield of Allotype.
He most often published in these fields:
- Immunology (79.51%)
- Antibody (50.24%)
- Genotype (23.41%)
What were the highlights of his more recent work (between 2011-2021)?
- Antibody (50.24%)
- Immunology (79.51%)
- Allele (21.95%)
In recent papers he was focusing on the following fields of study:
Janardan P. Pandey mainly focuses on Antibody, Immunology, Allele, Genotype and Genetics.
His work deals with themes such as Immunosurveillance, Virus, Human cytomegalovirus, Virology and Immunity, which intersect with Antibody.
His Immunology study focuses mostly on Humoral immunity, Immunoglobulin G, Antigen, Immune system and Human leukocyte antigen.
His work in the fields of Allele, such as Haplotype, overlaps with other areas such as Schizophrenia.
His Genotype research integrates issues from Rituximab and Population study.
His study on Longevity also encompasses disciplines like
- Public health that connect with fields like Genome-wide association study,
- Allele frequency that intertwine with fields like Allotype.
Between 2011 and 2021, his most popular works were:
- Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection (277 citations)
- Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults. (153 citations)
- Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults. (89 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Antibody
His primary scientific interests are in Immunology, Antibody, Immunoglobulin G, Genotype and Allele.
Janardan P. Pandey works mostly in the field of Immunology, limiting it down to concerns involving Glioma and, occasionally, Locus.
His Antibody study combines topics in areas such as Virus, Human cytomegalovirus and Virology.
His Genotype research includes themes of Breast cancer and Population study.
His Breast cancer study combines topics from a wide range of disciplines, such as Antigen, Case-control study and Epidermal growth factor receptor.
His Allele research is under the purview of Genetics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
